|
Oncology and immunology represent a specialty marketplace. We function exceptionally well in this unique environment where the science is compelling; diagnosis, prognosis, and treatment are complex; and intellectual rigor is imperative. We are motivated to make a significant impact—and we do so daily—by setting and achieving high expectations, thinking originally, behaving differently, and ceaselessly pursuing positive change.
The medical and academic disciplines of oncology and immunology require a unique vocabulary to create and communicate effectively. This is a dynamic market environment, populated by more than 600 compounds in clinical development—each requiring complicated strategic competitive assessments. We understand that because emerging data is the key driver of product use in this marketplace, prescribing patterns are different here than in others.
As a result, strategic thinking and planning must be equally distinctive. The evolving direct-to-patient segment within this specialty is unlike that of any other pharmaceutical category. Thus, connectivity to advocacy groups and an understanding of personal patient insight are critical.
|